Savastano Maria Cristina, Nociti Viviana, Giannuzzi Federico, Cestrone Valentina, Carlà Matteo Mario, Fossataro Claudia, Biagini Ilaria, Rizzo Clara, Kilian Raphael, Bisurgi Marco, Calabresi Paolo, Mirabella Massimiliano, Rizzo Stanislao
From the Ophthalmology Unit, Fondazione Policlinico Universitario A. Gemelli, IRCCS (M.C.S., F.G., V.C., M.M.C., C.F., S.R.), Rome, Italy; Catholic University of the Sacred Heart (M.C.S., V.N., F.G., V.C., M.M.C., C.F., I.B., S.R.), Rome, Italy.
Catholic University of the Sacred Heart (M.C.S., V.N., F.G., V.C., M.M.C., C.F., I.B., S.R.), Rome, Italy; Centro di Ricerca Sclerosi Multipla (CERSM), Università Cattolica (V.N., M.B., M.M.), Rome, Italy.
Am J Ophthalmol. 2024 Nov;267:41-49. doi: 10.1016/j.ajo.2024.06.011. Epub 2024 Jun 18.
To evaluate ophthalmological, neurological, radiological, and laboratory data in patients with multiple sclerosis (MS) and to identify new ophthalmological factors that could be helpful as biomarkers of the disease, potentially leading to an earlier prediction of disease course and disability progression.
Retrospective, cross-sectional-study.
Best-corrected visual acuity (BCVA), ophthalmological biomicroscopy of the anterior segment and fundus, structural optical coherence tomography (OCT) with retinal nerve fiber layer (RNFL) and ganglion cell complex (GCC), and OCT angiography (OCTA) with vascular density (VD) were performed. The following clinical and neuro-radiological features were assessed: MS phenotype, disease duration, clinical severity, type of treatment, and T2-weighted lesion and T1-weighted Gd+ enhancing lesion number on the brain and spinal cord MRI.
One hundred and six patients (212 eyes) were analyzed. Sixty-six of them (62.2%) had MS and 40 (37.8%) were matched healthy controls (HCs). patients with MS showed lower RNFL, GCC, and VD in the radial peripapillary capillary plexus than controls in both eyes (P < .05). By Performing a logistic regression with a distinct MS outcome for both eyes, we were able to demonstrate that the value that was most predictive of MS was the average GCC thickness (P = .009). Regression analysis demonstrated that patients with a higher T2-weighted lesions showed a lower RNFL thickness value and reduced GCC and VD values than those with a low lesion load (P < .01 and P < .05, respectively). Similarly, relapsing MS patients showed lower RNFL values (P < .05).
Several OCT and OCTA-optic nerve parameters could be useful prognostic biomarkers for the MS disease course in clinical practice. However, it is necessary to do additional research with larger sample sizes in order to validate these findings.
评估多发性硬化症(MS)患者的眼科、神经学、放射学和实验室数据,并确定可能有助于作为该疾病生物标志物的新眼科因素,从而有可能更早地预测疾病进程和残疾进展。
回顾性横断面研究。
进行最佳矫正视力(BCVA)、眼前节和眼底的眼科生物显微镜检查、视网膜神经纤维层(RNFL)和神经节细胞复合体(GCC)的结构光学相干断层扫描(OCT)以及血管密度(VD)的OCT血管造影(OCTA)。评估以下临床和神经放射学特征:MS表型、病程、临床严重程度、治疗类型以及脑和脊髓MRI上的T2加权病变和T1加权钆增强病变数量。
分析了106例患者(212只眼)。其中66例(62.2%)患有MS,40例(37.8%)为匹配的健康对照(HCs)。MS患者双眼的放射状视乳头周围毛细血管丛中的RNFL、GCC和VD均低于对照组(P < 0.05)。通过对双眼进行具有不同MS结果的逻辑回归分析,我们能够证明最能预测MS的指标是平均GCC厚度(P = 0.009)。回归分析表明,T2加权病变较高的患者,其RNFL厚度值、GCC和VD值均低于病变负荷较低的患者(分别为P < 0.01和P < 0.05)。同样,复发型MS患者的RNFL值较低(P < 0.05)。
在临床实践中,几个OCT和OCTA视神经参数可能是MS病程有用的预后生物标志物。然而,有必要进行更大样本量的进一步研究以验证这些发现。